| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.011 | 1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.0039 | 1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |